Cargando…
The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009
VNP20009 is a very effective anti-cancer agent and can specifically target tumors and inhibit tumor growth. It was assumed that the tumor targeting ability of VNP20009 correlated to its anticancer capacity. However, our observation contradicted to this assumption. Three VNP20009 mutant strains (Δsly...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348385/ https://www.ncbi.nlm.nih.gov/pubmed/27835896 http://dx.doi.org/10.18632/oncotarget.13217 |
_version_ | 1782514215858208768 |
---|---|
author | Zhang, Xiaoxin Xu, Qiaoqiao Yang, Lirun Lai, Yueyang Zhang, Zhuangzhuang Han, Chao Jiang, Chizhou Li, Jiahuang Shi, Yixin Hua, Zi-Chun |
author_facet | Zhang, Xiaoxin Xu, Qiaoqiao Yang, Lirun Lai, Yueyang Zhang, Zhuangzhuang Han, Chao Jiang, Chizhou Li, Jiahuang Shi, Yixin Hua, Zi-Chun |
author_sort | Zhang, Xiaoxin |
collection | PubMed |
description | VNP20009 is a very effective anti-cancer agent and can specifically target tumors and inhibit tumor growth. It was assumed that the tumor targeting ability of VNP20009 correlated to its anticancer capacity. However, our observation contradicted to this assumption. Three VNP20009 mutant strains (ΔslyA, ΔSTM3120 and ΔhtrA) with reduced fitness in normal tissues and unchanged fitness in tumors partially or completely lost their anti-cancer capacities. The genes slyA, STM3120 and htrA were required for survival within macrophages and were indispensable for tumor microenvironment remodeling by VNP20009. The infiltration of immune cells occurred less in the tumors of mice infected with the mutant strains. In addition, the mRNA levels of TNF-α and IL-1β were significantly decreased in the tumors of mice treated with the mutant strains. Our results indicate that the immune responses elicited by bacteria rather than the bacterial titer in tumors play a “decisive” role in VNP20009-mediated bacterial cancer therapy, which provides a novel perspective for the underlying mechanism of bacterial cancer therapy. |
format | Online Article Text |
id | pubmed-5348385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-53483852017-03-31 The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 Zhang, Xiaoxin Xu, Qiaoqiao Yang, Lirun Lai, Yueyang Zhang, Zhuangzhuang Han, Chao Jiang, Chizhou Li, Jiahuang Shi, Yixin Hua, Zi-Chun Oncotarget Research Paper VNP20009 is a very effective anti-cancer agent and can specifically target tumors and inhibit tumor growth. It was assumed that the tumor targeting ability of VNP20009 correlated to its anticancer capacity. However, our observation contradicted to this assumption. Three VNP20009 mutant strains (ΔslyA, ΔSTM3120 and ΔhtrA) with reduced fitness in normal tissues and unchanged fitness in tumors partially or completely lost their anti-cancer capacities. The genes slyA, STM3120 and htrA were required for survival within macrophages and were indispensable for tumor microenvironment remodeling by VNP20009. The infiltration of immune cells occurred less in the tumors of mice infected with the mutant strains. In addition, the mRNA levels of TNF-α and IL-1β were significantly decreased in the tumors of mice treated with the mutant strains. Our results indicate that the immune responses elicited by bacteria rather than the bacterial titer in tumors play a “decisive” role in VNP20009-mediated bacterial cancer therapy, which provides a novel perspective for the underlying mechanism of bacterial cancer therapy. Impact Journals LLC 2016-11-08 /pmc/articles/PMC5348385/ /pubmed/27835896 http://dx.doi.org/10.18632/oncotarget.13217 Text en Copyright: © 2016 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zhang, Xiaoxin Xu, Qiaoqiao Yang, Lirun Lai, Yueyang Zhang, Zhuangzhuang Han, Chao Jiang, Chizhou Li, Jiahuang Shi, Yixin Hua, Zi-Chun The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
title | The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
title_full | The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
title_fullStr | The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
title_full_unstemmed | The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
title_short | The genes slyA, STM3120 and htrA are required for the anticancer ability of VNP20009 |
title_sort | genes slya, stm3120 and htra are required for the anticancer ability of vnp20009 |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348385/ https://www.ncbi.nlm.nih.gov/pubmed/27835896 http://dx.doi.org/10.18632/oncotarget.13217 |
work_keys_str_mv | AT zhangxiaoxin thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT xuqiaoqiao thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT yanglirun thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT laiyueyang thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT zhangzhuangzhuang thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT hanchao thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT jiangchizhou thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT lijiahuang thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT shiyixin thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT huazichun thegenesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT zhangxiaoxin genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT xuqiaoqiao genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT yanglirun genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT laiyueyang genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT zhangzhuangzhuang genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT hanchao genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT jiangchizhou genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT lijiahuang genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT shiyixin genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 AT huazichun genesslyastm3120andhtraarerequiredfortheanticancerabilityofvnp20009 |